Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03177187
Title Combination Study of AZD5069 and Enzalutamide. (ACE)
Acronym ACE
Recruitment Terminated
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Institute of Cancer Research, United Kingdom
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR | CHE


No variant requirements are available.